These findings underscore the potential of RGMa as a therapeutic target in stroke treatment, suggesting that RGMa inhibitors could play a crucial role in improving outcomes for stroke patients by mitigating neuronal damage and enhancing neuroplasticity and repair. This evidence concerns the gene RGMA and Stroke.